Loading

Slzii.com Search

Search (News)

The Results Of Phase III Optitrop-Lung05 Study Of Sacituzumab Tirumotecan (Sac-TMT) Presented As An ASCO Oral Presentation And Simultaneously Published In The Lancet

The Results Of Phase III Optitrop-Lung05 Study Of Sacituzumab Tirumotecan (Sac-TMT) Presented As An ASCO Oral Presentation And Simultaneously Published In The Lancet
english health top

(MENAFN - PR Newswire) CHENGDU, China, May 29, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990) announced today that at the 2026 American Society of ...
2026-05-29 23:46:06

What are you doing?

0.094445943832397


News
News

Latest News and Headlines
(MENAFN - PR Newswire) CHENGDU, China, May 29, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the Company, 6990) ...
News